Table 3.
Validity and responsiveness indices for the DSMQ-R scales by study and diabetes type.
| Studies | DSMQ scales | Convergent criteria/outcome variables | Correlations (Pearson’s r) with criteria/outcomes | Baseline to follow-up changes (Cohen’s d) per scale | ||
|---|---|---|---|---|---|---|
| T1D | T2D | T1D | T2D | |||
| Study 1: Cross-sectional questionnaire study (2015–16); n=588 PWD (333 with T1D, 255 with T2D) | 20-item total score | HbA1c | -0.57‡ | -0.36‡ | n/a | n/a |
| Ketoacidosis past year (yes) | -0.22‡ | n/a | ||||
| With complications2 (yes) | -0.17† | -0.20† | ||||
| Treatment satisfaction (DTSQ score) | 0.63‡ | 0.53‡ | ||||
| Treatment motivation (DAS subscale) | 0.68‡ | 0.56‡ | ||||
| Treatment neglect (DAS subscale) | -0.77‡ | -0.68‡ | ||||
| Diabetes distress (PAID-5 score) | -0.42‡ | -0.27‡ | ||||
| Depressive symptoms (PHQ-9 score) | -0.49‡ | -0.43‡ | ||||
| 27-item total score1 | HbA1c | -0.57‡ | -0.49‡ | n/a | n/a | |
| Ketoacidosis past year (yes) | -0.21† | n/a | ||||
| With complications2 (yes) | -0.17† | -0.25* | ||||
| Treatment satisfaction (DTSQ score) | 0.64‡ | 0.53‡ | ||||
| Treatment motivation (DAS subscale) | 0.71‡ | 0.61‡ | ||||
| Treatment neglect (DAS subscale) | -0.76‡ | -0.69‡ | ||||
| Diabetes distress (PAID-5 score) | -0.47‡ | -0.40‡ | ||||
| Depressive symptoms (PHQ-9 score) | -0.53‡ | -0.48‡ | ||||
| Eating behavior | HbA1c | -0.43‡ | -0.31‡ | n/a | n/a | |
| Medication taking | HbA1c | -0.55‡ | -0.42‡ | n/a | n/a | |
| Glucose monitoring | HbA1c | -0.53‡ | -0.15* | n/a | n/a | |
| Physical activity | BMI | -0.10 | -0.28‡ | n/a | n/a | |
| Cooperation with diabetes team | Self-reported n of diabetologist visits past year | 0.14* | 0.09 | n/a | n/a | |
| Study 2: ‘Depression and Diabetes Control Trial’ (2016–17), prospective randomized trial, retest after six months n=198 PWD (131 with T1D, 67 with T2D) | 20-item total score | HbA1c | -0.36‡ | -0.30* | Total sample: 5.8 ±1.9 to 6.8 ±1.5‡ (d=0.66). EG: 6.0 ±1.8 to 6.8 ±1.6† (d=0.50), CG: 5.7 ±1.9 to 6.8 ±1.4‡ (d=0.82), p (time*group)=0.66 | Total sample: 5.3 ±1.5 to 6.1 ±1.6† (d=0.51). EG: 5.2 ±1.3 to 5.9 ±1.5† (d=0.51), CG: 5.8 ±1.9 to 6.8 ±1.5‡ (d=0.53), p (time*group)=0.89 |
| Summary of diabetes self-care activities past week (SDSCA total score) | 0.76‡ | 0.77‡ | ||||
| Often failing with diabetes routine (DDS item 8) | -0.69‡ | -0.54‡ | ||||
| Diabetes distress (PAID score) | -0.28‡ | -0.24* | ||||
| Diabetes acceptance (DAS score) | 0.51‡ | 0.40† | ||||
| Depressive symptoms (PHQ-9 score) | -0.28† | -0.22 | ||||
| 27-item total score1 | HbA1c | -0.39‡ | -0.32* | Total sample: 5.8 ±1.9 to 6.9 ±1.4‡ (d=0.72). EG: 6.0 ±1.8 to 6.9 ±1.5‡ (d=0.59), CG: 5.6 ±2.0 to 6.9 ±1.4‡ (d=0.85), p (time*group)=0.49 | Total sample1: 5.6 ±1.6 to 6.4 ±1.6† (d=0.57). EG: 5.3 ±1.1 to 6.5 ±1.2‡ (d=1.44), CG: 6.1 ±2.1 to 6.2 ±2.1 (d=0.06), p (time*group)=0.15 | |
| Summary of diabetes self-care activities past week (SDSCA total score) | 0.73‡ | 0.76‡ | ||||
| Often failing with diabetes routine (DDS item 8) | -0.70‡ | -0.49‡ | ||||
| Diabetes distress (PAID score) | -0.31‡ | -0.05 | ||||
| Diabetes acceptance (DAS score) | 0.51‡ | 0.33* | ||||
| Depressive symptoms (PHQ-9 score) | -0.31‡ | -0.13 | ||||
| Eating behavior | HbA1c | -0.34‡ | -0.01 | Total sample: 5.0 ±2.2 to 5.7 ±1.9† (d=0.37). EG: 5.2 ±2.3 to 5.8 ±2.1 (d=0.30), CG: 4.9 ±2.2 to 5.7 ±1.8* (d=0.42), p (time*group)=0.93 | Total sample: 3.9 ±1.8 to 5.0 ±1.8† (d=0.59). EG: 3.7 ±1.8 to 4.6 ±1.8† (d=0.51), CG: 4.3 ±2.0 to 5.9 ±1.8* (d=0.71), p (time*group)=0.68 | |
| Healthy eating past week (SDSCA General Diet scale) | 0.67‡ | 0.65‡ | ||||
| Not sticking to a good meal plan (DDS item 12) | -0.57‡ | 0.54‡ | ||||
| Medication taking | HbA1c | -0.43‡ | -0.36† | Total sample: 7.8 ±2.7 to 8.8 ±1.8‡ (d=0.47). EG: 7.9 ±2.6 to 8.8 ±1.8* (d=0.43), CG: 7.7 ±2.9 to 8.8 ±1.9† (d=0.49), p (time*group)=0.74 | Total sample: 8.0 ±2.5 to 8.6 ±2.1‡ (d=0.27). EG: 7.9 ±2.5 to 8.4 ±2.2 (d=0.23), CG: 8.3 ±2.5 to 9.0 ±1.9 (d=0.28), p (time*group)=0.51 | |
| Self-reported n of daily insulin injections | 0.27† | -0.14 | ||||
| Glucose monitoring | HbA1c | -0.29† | -0.39† | Total sample: 5.5 ±3.4 to 7.3 ±2.5‡ (d=0.61). EG: 5.6 ±3.3 to 7.0 ±2.7† (d=0.48), CG: 5.3 ±3.5 to 7.5 ±2.4‡ (d=0.73), p (time*group)=0.20 | Total sample: 5.3 ±3.6 to 6.9 ±3.0‡ (d=0.64). EG: 4.7 ±3.6 to 6.6 ±3.0‡ (d=0.78), CG: 6.8 ±3.5 to 7.8 ±3.1* (d=0.39), p (time*group)=0.90 | |
| SMBG past week (SDSCA Blood Sugar Testing scale) | 0.59‡ | 0.81‡ | ||||
| Not testing sugar frequently enough (DDS item 6) | -0.74‡ | -0.69‡ | ||||
| Self-reported n of daily SMBG checks | 0.36‡ | 0.61‡ | ||||
| Physical activity | BMI | -0.05 | -0.35† | Total sample: 5.1 ±3.0 to 5.4 ±3.0 (d=0.13). EG: 5.2 ±2.7 to 5.5 ±2.8 (d=0.12), CG: 4.9 ±3.3 to 5.3 ±3.3 (d=0.19), p (time*group)=0.99 | Total sample: 4.2 ±2.4 to 3.9 ±2.6 (d=0.10). EG: 4.2 ±2.3 to 4.2 ±2.7 (d=0.00), CG: 4.4 ±2.7 to 3.2 ±2.1 (d=0.37), p (time*group)=0.23 | |
| Physical exercise past week (SDSCA Exercise scale) | 0.73‡ | 0.72‡ | ||||
| Cooperation with diabetes team | Self-reported n of diabetologist visits past half year | 0.20* | 0.35† | Total sample: 7.9 ±2.3 to 8.5 ±1.7* (d=0.28). EG: 8.0 ±2.3 to 8.5 ±1.9 (d=0.22), CG: 7.8 ±2.4 to 8.4 ±1.5 (d=0.28), p (time*group)=0.89 | Total sample: 8.1 ±2.1 to 8.1 ±2.1 (d=0.00). EG: 8.1 ±1.8 to 8.3 ±1.8 (d=0.11), CG: 8.1 ±2.7 to 7.7 ±2.7 (d=0.17), p (time*group)=0.35 | |
| Not having a diabetes doctor (DDS item 15) | -0.30† | -0.57‡ | ||||
| Study 3: Five-year FU of the DIAMOS-ECCE HOMO cohort (2017–18), cross-sectional study n=298 PWD (191 with T1D, 107 with T2D) | 20-item total score | HbA1c | -0.41‡ | -0.34‡ | n/a | n/a |
| Often failing with diabetes routine (DDS item 8) | -0.64‡ | -0.72‡ | ||||
| Diabetes distress (PAID score) | -0.32‡ | -0.34‡ | ||||
| Diabetes acceptance (DAS score) | 0.65‡ | 0.61‡ | ||||
| Depressive symptoms (PHQ-9 score) | -0.24† | -0.21* | ||||
| 27-item total score1 | HbA1c | -0.42‡ | -0.24* | n/a | n/a | |
| Often failing with diabetes routine (DDS item 8) | -0.61‡ | -0.67‡ | ||||
| Diabetes distress (PAID score) | -0.26‡ | -0.29† | ||||
| Diabetes acceptance (DAS score) | 0.63‡ | 0.57‡ | ||||
| Depressive symptoms (PHQ-9 score) | -0.21† | -0.26* | ||||
| Eating behavior | HbA1c | -0.29‡ | -0.35‡ | n/a | n/a | |
| Not sticking to a good meal plan (DDS item 12) | 0.50‡ | 0.54‡ | ||||
| Medication taking | HbA1c | -0.36‡ | -0.35‡ | n/a | n/a | |
| Self-reported n of daily insulin injections | 0.01 | 0.06 | ||||
| Glucose monitoring | HbA1c | -0.36‡ | -0.23* | n/a | n/a | |
| Not testing sugar frequently enough (DDS item 6) | -0.67‡ | -0.72‡ | ||||
| Self-reported n of daily glucose checks/scans/ readings | 0.33‡ | 0.39‡ | ||||
| Physical activity | BMI | -0.26‡ | -0.25* | n/a | n/a | |
| Cooperation with diabetes team | Not having a diabetes doctor (DDS item 15) | -0.31‡ | -0.14 | n/a | n/a | |
| Study 4: ‘DIA-LINK1’ (2019–20), prospective observational study, retest after three months n=203 PWT1D | 20-item total score | HbA1c | -0.29‡ | n/a | 5.8 ±1.7 to 6.4 ±1.5‡ (d=0.38) | n/a |
| Not giving diabetes as much attention as one should (T1-DDS item 28) | -0.61‡ | n/a | ||||
| Diabetes distress (PAID score) | -0.27‡ | n/a | ||||
| Diabetes acceptance (DAS-10 score) | 0.40‡ | n/a | ||||
| Depressive symptoms (CES-D score) | -0.32‡ | n/a | ||||
| Feeling guilty for neglecting diabetes treatment (mean of daily EMA ratings) | -0.42‡ | n/a | ||||
| Feeling overwhelmed by diabetes treatment (mean of daily EMA ratings) | -0.23† | n/a | ||||
| Mean sensor glucose (4 weeks) | -0.30‡ | n/a | ||||
| Time-below-range (<70 mg/dl) | -0.06 | n/a | ||||
| Time-in-range (70–180 mg/dl) | 0.31‡ | n/a | ||||
| Time-above-range (>180 mg/dl) | -0.27‡ | n/a | ||||
| Glucose variability (CV) | -0.27‡ | n/a | ||||
| 27-item total score1 | HbA1c | -0.33‡ | n/a | 6.1 ±1.7 to 6.6 ±1.4‡ (d=0.37) | n/a | |
| Not giving diabetes as much attention as one should (T1-DDS item 28) | -0.61‡ | n/a | ||||
| Diabetes distress (PAID score) | -0.29‡ | n/a | ||||
| Diabetes acceptance (DAS-10 score) | 0.41‡ | n/a | ||||
| Depressive symptoms (CES-D score) | -0.33‡ | n/a | ||||
| Feeling guilty for neglecting diabetes treatment (mean of daily EMA ratings) | -0.44‡ | n/a | ||||
| Feeling overwhelmed by diabetes treatment (mean of daily EMA ratings) | -0.24† | n/a | ||||
| Mean sensor glucose (4 weeks) | -0.33‡ | n/a | ||||
| Time-below-range (<70 mg/dl) | -0.04 | n/a | ||||
| Time-in-range (70–180 mg/dl) | 0.34‡ | n/a | ||||
| Time-above-range (>180 mg/dl) | -0.30‡ | n/a | ||||
| Glucose variability (CV) | -0.28‡ | n/a | ||||
| Eating behavior | HbA1c | -0.08 | n/a | 4.6 ±2.2 to 5.2 ±1.9‡ (d=0.35) | n/a | |
| Not eating as carefully as one should (T1-DDS item 2) | -0.55‡ | n/a | ||||
| Feeling that eating is out of control (T1-DDS item 23) | -0.48‡ | n/a | ||||
| Medication taking | HbA1c | -0.36‡ | n/a | 7.6 ±2.5 to 8.2 ±2.4† (d=0.25) | n/a | |
| Time-in-range (70–180 mg/dl) | 0.33‡ | n/a | ||||
| Not taking as much insulin as one should (T1-DDS item 8) | -0.45‡ | n/a | ||||
| Self-reported n of daily insulin injections | 0.22† | n/a | ||||
| Glucose monitoring | HbA1c | -0.42‡ | n/a | 6.1 ±2.7 to 6.8 ±2.3‡ (d=0.29) | n/a | |
| Time-in-range (70–180 mg/dl) | 0.36‡ | n/a | ||||
| Not checking glucose level as often as one should (T1-DDS item 12) | -0.70‡ | n/a | ||||
| Self-reported n of daily glucose checks/scans/ readings | 0.40‡ | n/a | ||||
| Physical activity | BMI | -0.15* | n/a | 5.5 ±3.2 to 5.6 ±3.0 (d=0.04) | n/a | |
| Cooperation with diabetes team | Can’t tell diabetes doctor what is on mind (T1-DDS item 7) | -0.27‡ | n/a | 8.1 ±2.2 to 8.3 ±1.9 (d=0.11) | n/a | |
| Diabetes doctor doesn’t understand what it’s like to have diabetes (T1-DDS item 18) | -0.20† | n/a | ||||
| Study 5: ‘DIA-LINK2’ (2020–21), prospective observational study, retest after three months n=180 PWT2D | 20-item total score | HbA1c | n/a | -0.20† | n/a | 5.4 ±1.9 to 6.4 ±1.8‡ (d=0.54) |
| Often failing with diabetes routine (DDS item 8) | n/a | -0.40‡ | ||||
| Diabetes distress (PAID score) | n/a | -0.33‡ | ||||
| Diabetes acceptance (DAS-10 score) | n/a | 0.46‡ | ||||
| Depressive symptoms (CES-D score) | n/a | -0.23† | ||||
| Feeling guilty for neglecting diabetes treatment (mean of daily EMA ratings) | n/a | -0.43‡ | ||||
| Self-rated quality of self-management overall (mean of daily EMA ratings) | n/a | 0.47‡ | ||||
| 27-item total score1 | HbA1c | n/a | -0.25† | n/a | 5.8 ±1.9 to 6.9 ±1.7‡ (d=0.61) | |
| Often failing with diabetes routine (DDS item 8) | n/a | -0.43‡ | ||||
| Diabetes distress (PAID score) | n/a | -0.39‡ | ||||
| Diabetes acceptance (DAS-10 score) | n/a | 0.54‡ | ||||
| Depressive symptoms (CES-D score) | n/a | -0.37‡ | ||||
| Feeling guilty for neglecting diabetes self- management (mean of daily EMA ratings) | n/a | -0.37‡ | ||||
| Self-rated quality of self-management overall (mean of daily EMA ratings) | n/a | 0.44‡ | ||||
| Eating behavior | HbA1c | n/a | -0.08 | n/a | 4.2 ±2.3 to 5.6 ±2.3‡ (d=0.61) | |
| Not sticking to a good meal plan (DDS item 12) | n/a | -0.53‡ | ||||
| Diet promoting good glucose control (EMA ratings) | n/a | 0.44‡ | ||||
| Diet beneficial for weight (EMA ratings) | n/a | 0.46‡ | ||||
| Medication taking | HbA1c | n/a | -0.22† | n/a | 7.4 ±3.0 to 8.1 ±2.3† (d=0.26) | |
| Self-reported n of daily insulin injections | n/a | 0.00 | ||||
| Medical diabetes treatment appraisal (EMA ratings) | n/a | 0.33‡ | ||||
| Glucose monitoring | HbA1c | n/a | -0.08 | n/a | 5.3 ±3.2 to 6.8 ±2.8‡ (d=0.50) | |
| Not testing sugar frequently enough (DDS item 6) | n/a | -0.57‡ | ||||
| Self-reported n of daily glucose checks/scans/readings | n/a | 0.41‡ | ||||
| Physical activity | Level of physical activity contributing to good diabetes management (EMA ratings) | n/a | 0.58‡ | n/a | 4.1 ±3.1 to 5.1 ±3.0‡ (d=0.36) | |
| BMI | n/a | -0.31‡ | ||||
| HbA1c | n/a | -0.15* | ||||
| Cooperation with diabetes team | Not having a doctor for diabetes (DDS item 15) | n/a | -0.39‡ | n/a | 8.2 ±1.9 to 8.1 ±1.9 (d=0.05) | |
Displayed are criterion-related correlations and indices of change (Cohen’s d) from baseline to 6-month follow-up for each DSMQ-R scale stratified by study and diabetes type.
Indication of two-tailed significance: *p < 0.05, †p < 0.01, ‡p < 0.001.
BMI, body mass index; CES-D, Center for Epidemiologic Studies Depression Scale; CG, control group; CV, coefficient of variation; DAS, Diabetes Acceptance Scale; DDS, Diabetes Distress Scale; DM, diabetes mellitus; DTSQ, Diabetes Treatment Satisfaction Questionnaire; EG, experimental group; EMA, ecological momentary assessment; HbA1c, glycated hemoglobin; iscCGM, intermittently scanned continuous glucose monitoring; MDI, multiple daily (insulin) injections; n/a, not available; PAID, Problem Areas in Diabetes Scale; PHQ-9, Patient Health Questionnaire-9; PWD, people with diabetes; rtCGM, real-time continuous glucose monitoring; SDSCA, Summary of Diabetes Self-Care Activities; SMBG, self-monitoring of blood glucose; T1-DDS, Type 1 Diabetes Distress Scale; T1D, type 1 diabetes; T2D, type 2 diabetes.
1The 27-item total score, including the optional items 21–27 regarding intensive insulin treatment, was calculated for corresponding subgroups only [=full T1D group and those with T2D using bolus insulin and multiple daily insulin injections (MDI)].
2Assessed were diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic foot syndrome.